The use of biologicals in cutaneous allergies – present and future
In conclusion, although currently only one biological is approved in chronic urticaria, there is hope that a rapid better understanding of individual disease factors will support the development of other novel drugs in this field.
Source: Current Opinion in Allergy and Clinical Immunology - Category: Allergy & Immunology Tags: SKIN ALLERGY: Edited by Torsten Zuberbier and Thomas Werfel Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Dermatitis | Dermatology | Hives | Rituxan | Skin | Study | Xolair